Thrombosis vs SPARCtool

The Thrombosis Canada mobile app is your on-the-go resource for up-to-date clinical tools and practice guidelines related to thrombosis management. Built for healthcare professionals, this app offers quick access to: - Clinical Tools: Interactive tools designed to help with diagnosis, treatment, and risk assessment in managing patients with thrombosis. - Clinical Guides: Comprehensive guidelines from Thrombosis Canada covering various thrombosis conditions, treatments, and best practices. - Patient Resources: A wide range of materials including documents and videos, that can be shared with patients to educate them. Key Features: Whether you’re in the clinic, hospital, or consulting remotely, the Thrombosis Canada app ensures you have critical information at your fingertips. - User-Friendly Interface: Navigate easily through tools and guidelines with a simple and intuitive layout. Designed to be robust, yet concise enough to be applicable at the point of care. - Regular Updates: Always stay current with the latest guidelines and evidence-based practices. - Offline Access: Use clinical guides even without an internet connection. - Tailored for Healthcare Professionals: Developed voluntarily by Thrombosis CanadaTM members, internationally recognized as experts and peer reviewed by Thrombosis Canada committee. - Credibility: Reviewed for applicability to primary care by members of the College of Family Physicians of Canada and these were not supported financially by any external funders.

SPARCtool (Stroke Prevention in Afib Risk Calculator) is a clinical decision-support and educational tool to support informed conversations about stroke prevention in patients with atrial fibrillation. Enter patient risk factors to instantly calculate CHA₂DS₂-VASc and HAS-BLED scores. SPARCtool then transforms these scores into an intuitive visual comparison of the patient’s individualized annual risks of stroke and major bleeding across all antithrombotic treatment options. Features: • Individualized comparisons of antithrombotic therapy options • Annual stroke and major bleeding risk estimates • Treatment trade-off (Net Clinical Benefit) estimates • 100-person faces grids (risk pictures) • Therapy-specific cautions depending on patient attributes • Selected therapy options are retained on device between uses • References and explanatory notes • Shareable PDF results • Copyable EMR summary Beginning in 2003 as a Palm Pilot™ app, and since 2013 as a web app (www.sparctool.com), SPARCtool has been supporting clinicians and patients worldwide to have informed conversations about stroke prevention treatment decisions. SPARCtool is regularly updated to reflect current evidence about therapy options. Calculations occur locally on the device. SPARCtool does not collect or transmit patient information. SPARCtool supports learning and informed clinical conversations. It does not replace clinical judgment, individualized professional advice, or consideration of current clinical guidelines and product information. The author of SPARCtool has no relationship with sponsors or other industry interests involving atrial fibrillation or its therapies.